Status:
NOT_YET_RECRUITING
Observational Study on the Impact of Herpes Zoster Vaccine on the Incidence of Herpes Zoster and Survival in Lung Cancer Patients
Lead Sponsor:
The First Affiliated Hospital of Guangzhou Medical University
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the impact of herpes zoster vaccine on the incidence of herpes zoster and survival in lung cancer patients, and to explore its preventive effect and safety.
Eligibility Criteria
Inclusion
- Male or female patients \>=18 years of age; 2.Histological diagnosis of NSCLC, including both non-small cell lung cancer and small cell lung cancer, regardless of whether they are in the early, locally advanced stage or advanced stage, and regardless of whether they have received surgery, radiotherapy, chemotherapy or other treatments; 3. Never received herpes zoster vaccine
Exclusion
- Patients having other factors that preventing researchers from enrollment them.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2030
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07170059
Start Date
October 1 2025
End Date
October 1 2030
Last Update
September 12 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.